These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31158331)

  • 1. Philadelphia chromosome-positive acute lymphoblastic leukemia with an e14a3 BCR-ABL1 fusion: The role of molecular monitoring.
    Crampe M; Langabeer SE; O'Brien D; Ryan E; Bacon CL
    Hematol Oncol Stem Cell Ther; 2020 Sep; 13(3):166-167. PubMed ID: 31158331
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current treatment of philadelphia chromosome-positive acute lymphoblastic leukemia].
    Sugiura I
    Rinsho Ketsueki; 2014 Oct; 55(10):1972-80. PubMed ID: 25297762
    [No Abstract]   [Full Text] [Related]  

  • 3. Significance of Measurable Residual Disease in Adult Philadelphia Chromosome-Positive ALL: A GRAAPH-2014 Study.
    Kim R; Chalandon Y; Rousselot P; Cayuela JM; Huguet F; Balsat M; Passet M; Chevallier P; Hicheri Y; Raffoux E; Leguay T; Chantepie S; Maury S; Hayette S; Solly F; Braun T; De Prijck B; Cacheux V; Salanoubat C; Farnault L; Guibaud I; Lamarque M; Gastaud L; Lemasle E; Brissot E; Tavernier E; Bilger K; Villate A; Soulier J; Graux C; Lhéritier V; Dombret H; Boissel N; Clappier E
    J Clin Oncol; 2024 Sep; 42(26):3140-3150. PubMed ID: 39028928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impacts of BCR-ABL1 mutations in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation.
    Tachibana T; Najima Y; Akahoshi Y; Hirabayashi S; Harada K; Doki N; Uchida N; Fukuda T; Sawa M; Ogata M; Takada S; Tanaka M; Matsuhashi Y; Tanaka J; Onizuka M; Ichinohe T; Atsuta Y; Kako S;
    Ann Hematol; 2020 Oct; 99(10):2393-2404. PubMed ID: 32803312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Philadelphia-positive Acute Lymphoblastic Leukemia: Do We Still Need Allogeneic Transplantation? Argument "Pro".
    Bachanova V
    Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S10-S15. PubMed ID: 28760293
    [No Abstract]   [Full Text] [Related]  

  • 6. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).
    Wrzesień-Kuś A; Robak T; Pluta A; Zwolińska M; Wawrzyniak E; Wierzbowska A; Skotnicki A; Jakubas B; Hołowiecki J; Nowak K; Kuliczkowski K; Mazur G; Haus O; Dmoszyńska A; Adamczyk-Cioch M; Jedrzejczak WW; Paluszewska M; Konopka L; Pałynyczko G
    Ann Hematol; 2006 Jun; 85(6):366-73. PubMed ID: 16523310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: final results of the GIMEMA LAL 0904 study.
    Chiaretti S; Vitale A; Vignetti M; Piciocchi A; Fazi P; Elia L; Falini B; Ronco F; Ferrara F; De Fabritiis P; Luppi M; La Nasa G; Tedeschi A; Califano C; Fanin R; Dore F; Mandelli F; Meloni G; Foà R
    Haematologica; 2016 Dec; 101(12):1544-1552. PubMed ID: 27515250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCR/ABL1 Kinase Domain Mutation Monitoring: Could Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Benefit As Well?
    Andolina JR
    Acta Haematol; 2015; 134(2):69-70. PubMed ID: 25895547
    [No Abstract]   [Full Text] [Related]  

  • 9. SOHO State of the Art Updates and Next Questions, Measurable Residual Disease in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
    Short NJ; Jabbour E; Kantarjian H
    Clin Lymphoma Myeloma Leuk; 2024 Jul; 24(7):427-432. PubMed ID: 38485650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular response and prognostic factors of patients with Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia treated by imatinib with chemotherapy].
    Wang J; Huang X; Jiang B; Qin Y; Bao L; Jiang H; Chen H; Jia J; Yang S; Jiang Q
    Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):120-5. PubMed ID: 24606652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Philadelphia chromosome-positive acute lymphoblastic leukemia- current concepts and future perspectives.
    Faderl S; Garcia-Manero G; Thomas DA; Kantarjian HM
    Rev Clin Exp Hematol; 2002 Jun; 6(2):142-60; discussion 200-2. PubMed ID: 12196213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult acute lymphoblastic leukemia with a rare b3a3 type BCR/ABL1 fusion transcript.
    Kurita D; Hatta Y; Hojo A; Kura Y; Sawada U; Kanda Y; Takei M
    Cancer Genet; 2016 Apr; 209(4):161-5. PubMed ID: 26854094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The e1a3 BCR-ABL1 fusion transcript in philadelphia chromosome-positive acute lymphoblastic leukemia.
    Langabeer SE
    Ann Lab Med; 2015 Sep; 35(5):540-1. PubMed ID: 26206693
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful second allogeneic stem cell transplantation in second remission induced by dasatinib in a child with Philadelphia chromosome positive acute lymphoblastic leukemia.
    Millot F; Cividin M; Brizard F; Chomel JC; Méchinaud F; Guilhot F
    Pediatr Blood Cancer; 2009 Jul; 52(7):891-2. PubMed ID: 19202569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal residual disease-based long-term efficacy of reduced-intensity conditioning versus myeloablative conditioning for adult Philadelphia-positive acute lymphoblastic leukemia.
    Yoon JH; Min GJ; Park SS; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Lee S
    Cancer; 2019 Mar; 125(6):873-883. PubMed ID: 30521062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome after autologous
    Caillot L; Leclerc M; Sleiman EJR; Sloma I; Wagner-Ballon O; Claudel A; Beckerich F; Redjoul R; Robin C; Parinet V; Pautas C; Menouche D; Bouledroua S; Cabanne L; Nait-Sidenas Y; Gautier E; Rouard H; Lafon I; Chalandon Y; Boissel N; Caillot D; Maury S
    Haematologica; 2024 Apr; 109(4):1264-1268. PubMed ID: 38031800
    [No Abstract]   [Full Text] [Related]  

  • 17. Targeted therapy or transplantation for paediatric ABL-class Ph-like acute lymphocytic leukaemia?
    Tasian SK; Peters C
    Lancet Haematol; 2020 Dec; 7(12):e858-e859. PubMed ID: 33242441
    [No Abstract]   [Full Text] [Related]  

  • 18. Indications for allogeneic hematopoietic cell transplantation for adults with Philadelphia-chromosome negative acute lymphoblastic leukemia in first complete remission: all about MRD?
    Aldoss I; Pullarkat V
    Bone Marrow Transplant; 2019 Jan; 54(1):3-5. PubMed ID: 30446742
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular measurement of minimal residual disease in Philadelphia-positive acute lymphoblastic leukaemia.
    Radich JP
    Best Pract Res Clin Haematol; 2002 Mar; 15(1):91-103. PubMed ID: 11987918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of complete molecular response on survival in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Short NJ; Jabbour E; Sasaki K; Patel K; O'Brien SM; Cortes JE; Garris R; Issa GC; Garcia-Manero G; Luthra R; Thomas D; Kantarjian H; Ravandi F
    Blood; 2016 Jul; 128(4):504-7. PubMed ID: 27235138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.